Projects funded by the NCN
Association of TXNDC5 and calreticulin with decreased ER stress, allowing resistant multiple myeloma cells to by-pass proteasome inhibition.
2018/29/N/NZ5/00651
Keywords:
multiple myeloma proteasome inhibitors resistance ER stress TXNDC5 calreticulin
Descriptors:
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 15 - announced on 2018-03-15
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2019-02-18
Project end date (Y-m-d): 2022-02-17
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.